ASHLINN NASEMAN: Open Payments
NPI 1952738460 · BELLEFONTAINE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 18 payments from 8 companies in 2025. Trend: 2023 $718 · 2024 $444 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $95 |
| Tandem Diabetes Care, Inc. | 3 | $67 |
| CeQur Corporation | 1 | $52 |
| Dexcom, Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $42 |
| BETA BIONICS, INC. | 1 | $26 |
| Medtronic, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $15 |
Products named: t:slim X2 Insulin Pump with Control-IQ, CeQur Simplicity, Ozempic, Dexcom G6 Transmitter, MOUNJARO, Wegovy, iLet Bionic Pancreas, MINIMED 780G.
Industry payments across OH — which companies pay providers there.
